Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50

about

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50

Item

http://www.wikidata.org/entity/Q57484099

description

scientific article published on 04 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Reduced sensitivity of multipa ...... cer in men under the age of 50

@en

Reduced sensitivity of multipa ...... cer in men under the age of 50

@nl

type

Item

label

Reduced sensitivity of multipa ...... cer in men under the age of 50

@en

Reduced sensitivity of multipa ...... cer in men under the age of 50

@nl

prefLabel

Reduced sensitivity of multipa ...... cer in men under the age of 50

@en

Reduced sensitivity of multipa ...... cer in men under the age of 50

@nl

P1476

Reduced sensitivity of multipa ...... cer in men under the age of 50

@en

P2093

Anne-Maree Haynes

http://www.w3.org/2001/XMLSchema#string

Carlo Yuen

http://www.w3.org/2001/XMLSchema#string

Ilan Gielchinsky

http://www.w3.org/2001/XMLSchema#string

John Chang

http://www.w3.org/2001/XMLSchema#string

Matthijs J Scheltema

http://www.w3.org/2001/XMLSchema#string

Quoc Nguyen

http://www.w3.org/2001/XMLSchema#string

Ron Shnier

http://www.w3.org/2001/XMLSchema#string

Thomas Cusick

http://www.w3.org/2001/XMLSchema#string

Warick Delprado

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

Visualizing the prostate gland by MR imaging in young and old mice

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.

Prostate cancer in young men: an important clinical entity.

What Are the Recommended Timing and Screening Modalities in Women at Higher Risk for Developing Breast Cancer? A Clin-IQ.

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.

A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.

The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

P304

145-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/RRU.S169017

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A. Moses

Phillip D Stricker

P577

2018-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30324096

http://www.w3.org/2001/XMLSchema#string

P932

6174906

http://www.w3.org/2001/XMLSchema#string